Skip to content
Ferric carboxymaltose
Injectafer (ferric carboxymaltose) is an unknown pharmaceutical. Ferric carboxymaltose was first approved as Injectafer on 2013-07-25.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Injectafer
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ferric carboxymaltose
Tradename
Company
Number
Date
Products
INJECTAFERAmerican RegentN-203565 RX2013-07-25
4 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
injectaferNew Drug Application2021-11-01
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
FERRIC CARBOXYMALTOSE, INJECTAFER, AM REGENT
2024-11-19NPP
2024-04-28NS
Patent Expiration
Patent
Expires
Flag
FDA Information
Ferric Carboxymaltose, Injectafer, Am Regent
77547022028-02-15U-1432, U-2555, U-2556, U-2557, U-3312, U-3313, U-3314
88956122027-01-08U-1620, U-3050, U-3051, U-3115, U-3116, U-3315, U-3316
114330912027-01-08U-3435, U-3436, U-3437, U-3438
114785022027-01-08U-3472, U-3473, U-3474
76121092024-02-05DS, DP
93765052023-10-20DS, DP
111233212023-10-20DS, DPU-2555, U-2557, U-3312, U-3313
112916452023-10-20DS, DPU-3351, U-3352
115900972023-10-20DS, DPU-3312, U-3313
ATC Codes
No data
HCPCS
Code
Description
J1439
Injection, ferric carboxymaltose, 1 mg
Clinical
Clinical Trials
151 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Iron-deficiency anemiaD018798HP_0001891D50182219958
AnemiaD000740EFO_0004272D64.9121919344
Iron deficienciesD000090463E61.11387221
Heart failureD006333EFO_0003144I501169219
Inflammatory bowel diseasesD015212EFO_00037671315
Restless legs syndromeD012148EFO_0004270G25.813115
NeoplasmsD009369C802114
Colorectal neoplasmsD015179134
Systolic heart failureD054143EFO_1001207I50.201124
Replacement arthroplasty kneeD019645213
Show 23 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Female genital neoplasmsD005833112
Pancreatic neoplasmsD010190EFO_0003860C25112
Breast neoplasmsD001943EFO_0003869C5011
Ductal carcinoma breastD01827011
Inflammatory breast neoplasmsD05892211
Type 2 diabetes mellitusD003924EFO_0001360E1111
Ulcerative colitisD003093EFO_0000729K5111
Crohn diseaseD003424EFO_0000384K5011
Atrial fibrillationD001281EFO_0000275I48.011
Cardiovascular diseasesD002318EFO_0000319I9811
Show 6 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pulmonary arterial hypertensionD000081029112
Gastrointestinal stromal tumorsD046152EFO_0000505C49.A11
Chronic fatigue syndromeD015673EFO_0004540G93.3111
FibromyalgiaD005356EFO_0005687M79.111
ThrombocytosisD013922D75.8311
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ScoliosisD012600EFO_0004273M4111
HemiarthroplastyD06278511
Colonic neoplasmsD003110C1811
Altitude sicknessD000532EFO_1000782T70.2911
Ventricular functionD01627611
Vaccine-preventable diseasesD00007926311
Cardiac arrhythmiasD001145EFO_0004269I49.911
Myocardial infarctionD009203EFO_0000612I2111
Child developmentD00265711
Neurodevelopmental disordersD065886F8911
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFERRIC CARBOXYMALTOSE
INNferric carboxymaltose
Description
Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron. Prevention may also be used in low birth weight babies. They are taken by mouth, injection into a vein, or injection into a muscle. While benefits may be seen in days, up to two months may be required until iron levels return to normal.
Classification
Unknown
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID9007-72-1
RxCUI
ChEMBL IDCHEMBL2108597
ChEBI ID
PubChem CID
DrugBank
UNII ID6897GXD6OE (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,795 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
5,282 adverse events reported
View more details